Growth Metrics

Integra Lifesciences Holdings (IART) Net Income towards Common Stockholders (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -170.95%
Dec 31, 2025 68.47%
Sep 30, 2025 98.88%
Jun 30, 2025 -1,813.86%
Mar 31, 2025 -230.14%
Dec 31, 2024 281.72%
Sep 30, 2024 13.76%
Jun 30, 2024 -277.99%
Mar 31, 2024 -116.54%
Dec 31, 2023 1.73%
Sep 30, 2023 365.99%
Jun 30, 2023 -82.73%
Mar 31, 2023 -54.24%
Dec 31, 2022 6.07%
Sep 30, 2022 11.45%
Jun 30, 2022 36.13%
Mar 31, 2022 -27.51%
Dec 31, 2021 4.99%
Sep 30, 2021 23.27%
Jun 30, 2021 -22.75%
Mar 31, 2021 -51.05%
Dec 31, 2020 186.80%
Sep 30, 2020 8,863.41%
Jun 30, 2020 -104.02%
Mar 31, 2020 -40.07%
Dec 31, 2019 155.48%
Sep 30, 2019 -192.85%
Jun 30, 2019 -9.22%
Mar 31, 2019 30.30%
Dec 31, 2018 89.08%
Sep 30, 2018 16.87%
Jun 30, 2018 3.49%
Mar 31, 2018 -75.22%
Dec 31, 2017 1,304.08%
Sep 30, 2017 -70.84%
Jun 30, 2017 69.46%
Jun 30, 2015 -109.74%
Mar 31, 2015 -3.37%
Dec 31, 2014 -496.45%
Sep 30, 2014 -83.07%
Jun 30, 2014 118.72%
Mar 31, 2014 -96.54%
Dec 31, 2013 310.01%
Sep 30, 2013 -2,095.39%
Jun 30, 2013 125.22%
Mar 31, 2013 -147.15%
Dec 31, 2012 -3.22%
Sep 30, 2012 55.17%
Jun 30, 2012 27.21%
Mar 31, 2012 46.78%
Dec 31, 2011 -59.44%
Sep 30, 2011 1,508.44%
Jun 30, 2011 -93.91%
Mar 31, 2011 -38.92%
Dec 31, 2010 14.10%
Sep 30, 2010 8.75%
Jun 30, 2010 -0.43%
Mar 31, 2010 161.46%
Dec 31, 2009 -271.60%
Sep 30, 2009 28.57%